Cure Ventures logo

Cure Ventures

North America, California, United States, Newport Beach

Description

Cure Ventures is a venture firm focusing on investments in life sciences and medical technologies

Investor Profile

Cure Ventures has made 3 investments, with 1 in the past 12 months and 67% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cure Ventures frequently co-invest with?

Alaska Permanent Fund
North America, Alaska, United States, Juneau
Co-Investments: 1
EC
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
SV
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
The Column Group
North America, California, United States, San Francisco
Co-Investments: 1
Blackbird Ventures
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Pictet Alternative Advisors
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1

What are some of recent deals done by Cure Ventures?

Tasca

Boston, Massachusetts, United States

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

BiopharmaBiotechnologyHealth CareWellness
Series ADec 10, 2024
Amount Raised: $52,000,000
Clasp Therapeutics

Cambridge, Massachusetts, United States

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.

BiotechnologyTherapeutics
Series AMar 20, 2024
Amount Raised: $150,000,000
Kenai Therapeutics

San Diego, California, United States

Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.

BiotechnologyHealth CareMedicalTherapeutics
Series AFeb 29, 2024
Amount Raised: $82,000,000